PET scans may improve bladder cancer staging

NCT ID NCT04053101

Completed Knowledge-focused Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study looked at whether FDG-PET CT scans can more accurately stage muscle invasive bladder cancer compared to standard CT scans. Researchers reviewed records of 130 patients who had PET CT scans at diagnosis. The goal was to see if PET CT better detects cancer spread to lymph nodes or other areas, which could guide treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: FDG-PET CT scan
What this could lead to: If successful, this could show that PET CT scans are more accurate for staging bladder cancer, leading to better treatment decisions.
What could go wrong: This is a retrospective study, not a controlled trial, so results may not be definitive. The scans are for staging, not treatment, so direct patient benefit is limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infiltrating bladder urothelial carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MUSCLE-INVASIVE BLADDER CANCER

Contacts and locations

Locations

Centre Hospitalier Universitaire de Bordeaux

Bordeaux, 33076, France
Institut Bergonie

Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.